Tech Center 1600 • Art Units: 1635 1674
This examiner grants 71% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17769322 | Treatment of Airway Conditions by Modulation of MiR200 Family MicroRNAs | Non-Final OA | The Regents of the University of California |
| 18299509 | MODULATION OF GENE EXPRESSION AND SCREENING FOR DEREGULATED PROTEIN EXPRESSION | Non-Final OA | University of Southampton |
| 18158290 | COMPOSITIONS AND METHODS FOR MODULATING PKK EXPRESSION | Non-Final OA | Ionis Pharmaceuticals, Inc. |
| 17481679 | COMPOSITIONS AND METHODS FOR MODULATING TAU EXPRESSION | Non-Final OA | Ionis Pharmaceuticals, Inc. |
| 18207609 | MRNA THERAPY FOR POMPE DISEASE | Final Rejection | Translate Bio, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy